1. Dashboard

Pfizer NYSE: PFE

Invest Fact Sheet
Name Pfizer
Ticker PFE
Exchange NYSE
Sector Health Care
Industry Drug Manufacturers - Diversified
Price 36.50
52W Low/High 28.49 / 42.56
Market cap 203 B
1Y Total Return -0.87%
Average
1Y Volatility 35.99%
Low Risk
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions

Details

Ticker PFE
Name Pfizer
ISIN US7170811035
CUSIP 717081103
Exchange NYSE
Sector Health Care
Industry Drug Manufacturers - Diversified
Country USA
Currency U.S. Dollar
In Index(ices)
  • US S&P 500 Index
  • US S&P 100 Index

Share as of 1/20/21

Close Price 36.50
52W Low/High 28.49 / 42.56
Market cap 203 B
1Y Total Return -0.87%
Average
1Y Volatility 35.99%
Low Risk
Beta 0.34
PE (trailing) 23.40
Average
12M Dividends 1.5
Last Dividend Date 11/17/20
Dividend Yield 4.11%

Fin. Strength

Net Profit Margin 17.9%
Cash from Op. / Cur. Liabilities 0.37
Diluted Earnings / Share 1.56
ROE 13.3%
ROIC 6.3%
Price / Revenue 4.2
Price / Book 3.2
Price / CF 16.4
Current Ratio 1.4
Cur.Liabilities / Tot.Liabilities 0.3
Financial Leverage 0.97
in Mils USD
rolling-year up to September
 
Income Statement 2020 2019 2018 2017 2016 2015  
Revenue
48,648
53,039
53,373
52,471
53,244
47,922
Gross Profit
38,852
42,353
41,944
41,288
40,724
38,983
R&D
9,039
8,285
7,864
7,900
7,708
8,550
EBITDA
13,586
24,485
20,072
18,354
12,821
16,147
Operating Income
8,499
10,155
13,786
12,128
7,220
11,123
Net Income exc. Extra
8,685
16,217
23,821
9,809
6,268
8,360
per Share  
Diluted avg Shares
5,633
5,649
5,986
6,041
6,150
6,243
EPS exc. Extra
1.56
2.88
3.96
1.62
1.01
1.33
Dividend
1.50
1.42
1.34
1.26
1.18
1.10
  
Div. Yield (an.)
4.16%
3.92%
3.04%
3.53%
3.48%
3.45%
  
Balance Sheet 2020 2019 2018 2017 2016 2015  
Total Assets
178,983
170,446
167,838
172,151
178,430
170,867
Cash, Eq & Invt ShortTerm
21,912
9,087
17,239
16,925
14,371
20,658
Total Current Assets
47,739
33,459
41,583
40,291
38,501
45,001
Total Non-Current Assets
131,244
136,987
126,255
131,860
139,929
125,866
Intangibles
90,829
97,660
100,920
105,799
110,519
90,514
Total Liabilities
113,487
105,051
96,174
111,041
114,829
103,743
Total Current Liabilities
34,154
36,974
29,013
28,217
34,759
27,845
Long Term Debt
79,333
68,077
67,161
82,824
80,070
75,898
Shareholder equity
65,259
65,103
71,319
60,770
63,306
66,838
Cash Flow 2020 2019 2018 2017 2016 2015  
Cash from Operations
12,547
13,557
18,178
15,754
15,049
15,389
Depreciation
5,115
6,267
6,317
6,244
5,632
5,064
Cash from Investing
-15,434
-1,876
530
-3,068
-6,928
-2,270
Capex
2,231
2,660
2,177
2,213
1,892
1,230
Cash from Financing
1,698
-12,452
-17,777
-11,920
-8,209
-12,242
Stock Issued
297
-13,432
-5,863
-4,271
-3,956
-5,896
Debt (LT) Issued
10,250
9,696
-3,047
488
3,227
510
Free Cash Flow
6,346
29,270
29,663
5,294
16,051
20,125
Ratios 2020 2019 2018 2017 2016 2015  
Net Profit Margin
17.9%
30.6%
44.6%
18.7%
11.8%
17.4%
  
NCFO / Op.Income
147.6%
133.5%
131.9%
129.9%
208.4%
138.4%
  
Current Ratio
1.4
0.9
1.4
1.4
1.1
1.6
  
Financial Leverage D/E
0.97
0.81
0.58
0.72
0.70
0.58
  
Return on Capital Avg
6.3%
11.7%
18.2%
5.8%
4.7%
6.1%
  
Return on Shareholder Equity
13.3%
23.8%
36.1%
15.8%
9.6%
11.5%
  

Data

Fundamentals

More Info

No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available